IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4789
Positioning
Market Dominance
Manufacturing
Pharmaceutical Products
$2M
Francisco D. Salva
We are an early-stage clinical biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. We were incorporated under the laws of the state of Delaware on January 2, 2014. Our principal executive offices are located at 21 Business Park Drive, Branford, Connecticut.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 32.9% | 20.5% | 48.8% | 30.6% | 24.4% | 7.7% | 0.9% | 32.0x | $148.6B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.4% | 7.5% | 68.3% | 19.5% | 18.2% | 29.0% | 0.0% | 0.0x | $84M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AZTR Azitra, Inc. | 24 | 19 | 2 | 15 | - | - | -427.0% | -226.3% | - | - | - | -100.0% | 0.0% | 89.0x | $2M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -1.9% | 0.9% | 44.1% | 2.5% | 1.0% | 6.7% | 0.0% | 0.2x | - | REF |
Azitra, Inc. (AZTR) receives a "Avoid" rating with a composite score of 24.4/100. It ranks #4789 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for AZTR.
View All RatingsROE proxy -427.0% (sector -1.9%)
GM N/A vs sector 44%, OM N/A vs sector 3%
Capital turnover N/A
Rev growth -100%, 3yr history
Interest coverage -7442.2x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate Azitra, Inc. (AZTR) as Avoid with a composite score of 24.4/100 at a current price of $0.18. The stock falls in the bottom quintile, and the multi-factor weakness suggests a high probability of continued underperformance.
Azitra, Inc. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 24.4/100 places it at rank #4789 in our full universe.
No Moat
Medium
Poor
Fair Value
Stable competitive position in a defensive sector.
Weak momentum suggests persistent institutional selling pressure.
Below-average quality raises earnings sustainability concerns.
Vulnerability to macroeconomic shocks and interest rate volatility.
Azitra, Inc. represents a avoid based on multi-factor quantitative performance.
Our quantitative model flags Azitra, Inc. with an Avoid rating, assigning a composite score of 24.4/100 and 1 out of 5 stars. Ranked #4789 of 7,333 stocks, AZTR falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
Azitra, Inc. registers a weak quality score of just 19/100, indicating significant profitability challenges. The company reports a return on equity of -427.0% (sector avg: -1.9%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.
AZTR registers a value score of just 2/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 0.80x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
Azitra, Inc.'s investment score of 25/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -100.0% vs. a sector average of 6.7% and a return on assets of -226.3% (sector: 0.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
Azitra, Inc. is experiencing notably weak momentum with a score of just 15/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -100.0% year-over-year, while a beta of -0.09 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
AZTR's stability score of 33/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of -0.09 and a debt-to-equity ratio of 89.00x (sector avg: 0.2x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 51/100 for AZTR suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 89.00x), micro-cap liquidity risk. With a $2M market cap (micro-cap), Azitra, Inc. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Azitra, Inc. is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #4789 of 7,333 overall (35th percentile). Key comparisons include ROE of -427.0% trailing the -1.9% sector median. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While AZTR currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Value (2) would have the largest impact on the composite score.
ROE 22372% ABOVE SECTOR MEDIAN (FAVORABLE)
Debt/Equity 42281% ABOVE SECTOR MEDIAN
Div. Yield NaN% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list its financial arm in October 2025. Sony Group reported third-quarter FY23 sales growth of 22% year-on-year to $25.34 billion (¥3.75 trillion), beating the consensus of $24.62 billion. Adjusted EPS of $1.99 beat the consensus of $1.65. Sony revised its FY23 sales outlook to $86.62 billion (¥12.4 trillion), down from a prior forecast of ¥12.3 trillion versus the consensus of $87.32 billion. Sony Group shares fell 6.3% to $89.86 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Datasea Inc. (NASDAQ: DTSS) shares jumped 1,173% to $18.59. On Tuesday, Datasea posted a narrower second-quarter loss. Earlyworks Co., Ltd. (NASDAQ: ELWS) surged 416% to $2.35 on two passive stakes. enGene Holdings Inc. (NASDAQ: ENGN) jumped 95.5% to $14.90. The company’s CEO Jason Hanson is resigning due to personal family and health reasons, though he will continue to support the company as a strategic advisor after a successor is appointed. Concurrently, enGene announced a private placement of 20 million common shares at $10.00 per share, representing a 31% premium over the previous day’s closing price. Cineverse Corp. (NASDAQ: CNVS) surged 92.9% to $2.9899. Cineverse announced forthcoming launch of AI-powered movie search platform cineSearch. Cheche Group Inc. (NASDAQ: CCG) gained 74.3% to $5.49. MGO Global, Inc. (NASDAQ: MGOL) rose 66% to $0.6647. Cogent Biosciences, Inc. (NASDAQ: COGT) surged 62.7% to $8.89. Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) gained 35% to $1.29 after the company announced it received the first ever U.S. Patent approval for an orbiting blood oxygenation delivery system, a core technology of the INSPIRA ART500 device. Lyft, Inc. (NASDAQ: LYFT) shares gained 34.3% to $16.29 after the company reported fourth-quarter sales of $1.22 billion and gross bookings of $3.7 ...

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Wednesday. The Dow traded down 0.20% to 38,194.62 while the NASDAQ rose 0.19% to 15,686.43. The S&P 500 also rose, gaining, 0.11% to 4,958.84. Check This Out: Snap, American Express And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Industrials shares rose by 1% on Wednesday. In trading on Wednesday, energy shares fell by 0.2%. Top Headline Louisiana-Pacific Corp (NYSE: LPX) reported better-than-expected results for its fourth quarter. Louisiana-Pacific reported a fourth-quarter fiscal 2023 net sales decline of 6.7% year-over-year to $658 million, beating the consensus of $619.97 million. Adjusted EPS was 71 cents, up from 61 cents YoY, beating the consensus of 55 cents Equities Trading UP enGene Holdings Inc. (NASDAQ: ENGN) shares shot up 75% to $13.34. The company’s CEO Jason Hanson is resigning due to personal family and health reasons, though he will continue to support the company as a strategic advisor after a successor is appointed. Concurrently, enGene announced a private placement of 20 million common shares at $10.00 per share, representing a ...

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.11% to 38,313.27 while the NASDAQ rose 0.70% to 15,765.18. The S&P 500 also rose, gaining, 0.49% to 4,977.43. Check This Out: Snap, American Express And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Industrials shares rose by 1.1% on Wednesday. In trading on Wednesday, consumer staples shares fell by 0.6%. Top Headline Crude oil inventories in the U.S. surged by 12.018 million barrels in the week ending Feb. 9, compared to market estimates of a 2.56 million rise. Equities Trading UP enGene Holdings Inc. (NASDAQ: ENGN) shares shot up 83% to $13.95. The company’s CEO Jason Hanson is resigning due to personal family and health reasons, though he will continue to support the company as a strategic advisor after a successor is appointed. Concurrently, enGene announced a private placement of 20 million common shares at $10.00 per share, representing a 31% premium over the previous day’s closing price. Shares of Lyft, Inc. (NASDAQ:

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.20% to 38,350.89 while the NASDAQ rose 0.74% to 15,772.10. The S&P 500 also rose, gaining, 0.55% to 4,980.23. Check This Out: Snap, American Express And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Industrials shares rose by 1% on Wednesday. In trading on Wednesday, consumer staples shares fell by 0.4%. Top Headline The Kraft Heinz Company (NASDAQ: KHC) reported weaker-than-expected sales for its fourth quarter. Kraft Heinz posted adjusted earnings of 78 cents per share, beating market estimates of 77 cents per share. The company’s quarterly sales came in at $6.86 billion, missing expectations of $6.98 billion. Equities Trading UP Datasea Inc. (NASDAQ: DTSS) shares shot up 752% to $12.02. On Tuesday, Datasea posted a narrower second-quarter loss. Shares of Earlyworks Co., Ltd. (NASDAQ:

Quoin Pharmaceuticals reported a net loss of $6.28 per share in Q2 2025, which exceeded analyst estimates. The company is developing QRX003, a topical lotion for Netherton Syndrome, and made significant clinical and regulatory progress while increasing R&D spending.